Singh Jasvinder A, Chen Jason, Inacio Maria C S, Namba Robert S, Paxton Elizabeth W
Medicine Service, Birmingham VA Medical Center, Birmingham, AL, USA.
Department of Medicine at School of Medicine, and Division of Epidemiology at School of Public Health, University of Alabama, Faculty Office Tower 805B, 510 20th Street S, Birmingham, AL, 35294, USA.
BMC Musculoskelet Disord. 2017 Jan 9;18(1):8. doi: 10.1186/s12891-016-1385-0.
Well-designed studies of complications and readmission rates in patients undergoing total hip arthroplasty (THA) with osteonecrosis are lacking. Our objective was to examine if a diagnosis of osteonecrosis was associated with complications, mortality and readmission rates after THA.
We analyzed prospectively collected data from an integrated healthcare system's Total Joint Replacement Registry of adults with osteonecrosis vs. osteoarthritis (OA) undergoing unilateral primary THA during 2001-2012, in an observational cohort study. We examined mortality (90-day), revision (ever), deep (1 year) and superficial (30-day) surgical site infection (SSI), venous thromboembolism (VTE, 90-day), and unplanned readmission (90-day). Age, gender, race, body mass index, American Society of Anesthesiologists class, and diabetes were evaluated as confounders. We used logistic or Cox regression to calculate odds or hazard ratios (OR, HR) with 95% confidence intervals (CI).
Of the 47,523 primary THA cases, 45,252 (95.2%) had OA, and 2,271 (4.8%) had osteonecrosis. Compared to the OA, patients with osteonecrosis were younger (median age 55 vs. 67 years), and were less likely to be female (42.5% vs. 58.3%) or White (59.8% vs. 77.4%). Compared to the OA, the osteonecrosis cohort had higher crude incidence of 90-day mortality (0.7% vs. 0.3%), SSI (1.2% vs. 0.8%), unplanned readmission (9.6% vs. 5.2%) and revision (3.1% vs. 2.4%). After multivariable-adjustment, patients with osteonecrosis had a higher odds/hazard of mortality (OR: 2.48; 95% CI:1.31-4.72), SSI (OR: 1.67, 95%CI:1.11-2.51), unplanned 90-day readmissions (OR: 2.20; 95% CI:1.67-2.91) and a trend towards higher revision rate 1-year post-THA (HR: 1.32; 95% CI: 0.94-1.84), than OA patients.
Compared to OA, a diagnosis of osteonecrosis was associated with worse outcomes post-THA. A detailed preoperative discussion including the risk of complications is needed for informed consent from patients with osteonecrosis.
缺乏针对患有骨坏死的患者进行全髋关节置换术(THA)的并发症及再入院率的精心设计的研究。我们的目标是探讨骨坏死诊断是否与THA后的并发症、死亡率及再入院率相关。
在一项观察性队列研究中,我们分析了从一个综合医疗系统的全关节置换登记处前瞻性收集的数据,该数据来自2001年至2012年期间接受单侧初次THA的患有骨坏死与骨关节炎(OA)的成年患者。我们研究了死亡率(90天)、翻修率(任何时候)、深部(1年)和浅表(30天)手术部位感染(SSI)、静脉血栓栓塞(VTE,90天)以及非计划再入院率(90天)。将年龄、性别、种族、体重指数、美国麻醉医师协会分级和糖尿病作为混杂因素进行评估。我们使用逻辑回归或Cox回归来计算比值比或风险比(OR,HR)以及95%置信区间(CI)。
在47,523例初次THA病例中,45,252例(95.2%)患有OA,2,271例(4.8%)患有骨坏死。与OA患者相比,骨坏死患者更年轻(中位年龄55岁对67岁),女性比例更低(42.5%对58.3%),白人比例更低(59.8%对77.4%)。与OA患者相比,骨坏死队列的90天死亡率(0.7%对0.3%)、SSI(1.2%对0.8%)、非计划再入院率(9.6%对5.2%)和翻修率(3.1%对2.4%)的粗发病率更高。经过多变量调整后,与OA患者相比,骨坏死患者的死亡几率/风险更高(OR:2.48;95%CI:1.31 - 4.72)、SSI(OR:1.67,95%CI:1.11 - 2.51)、90天非计划再入院率(OR:2.20;95%CI:1.67 - 2.91),并且在THA后1年有翻修率升高的趋势(HR:1.32;95%CI:0.94 - 1.84)。
与OA相比,骨坏死诊断与THA后更差的结局相关。对于骨坏死患者,需要进行详细的术前讨论,包括并发症风险,以获得患者的知情同意。